Weina Yu

1.7k total citations · 2 hit papers
20 papers, 1.2k citations indexed

About

Weina Yu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Weina Yu has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Weina Yu's work include Immune cells in cancer (5 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Weina Yu is often cited by papers focused on Immune cells in cancer (5 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Weina Yu collaborates with scholars based in China and United States. Weina Yu's co-authors include Yi Zhang, Jingyao Lian, Ying Yue, Shasha Liu, Yi Zhang, Guohui Qin, Ting Li, Li Yang, Dan Wang and Li Yang and has published in prestigious journals such as Frontiers in Immunology, Advanced Science and Cancer Letters.

In The Last Decade

Weina Yu

19 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosenescence: a key player in cancer development

2020 322 citations Jingyao Lian, Ying Yue et al. Journal of Hematology & Oncology profile →
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment

2021 170 citations Weina Yu, Qingyang Lei et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weina Yu China	12	511	449	411	294	165	20	1.2k
Valeria Cancila Italy	17	526 1.0×	395 0.9×	402 1.0×	243 0.8×	151 0.9×	49	1.3k
Jingyao Lian China	19	529 1.0×	639 1.4×	553 1.3×	274 0.9×	207 1.3×	39	1.4k
Mahdi Abdoli Shadbad Iran	22	558 1.1×	454 1.0×	569 1.4×	339 1.2×	167 1.0×	60	1.3k
Cinzia Bagalá Italy	18	629 1.2×	251 0.6×	484 1.2×	198 0.7×	177 1.1×	36	1.3k
Zhihua Ruan China	21	391 0.8×	400 0.9×	318 0.8×	196 0.7×	122 0.7×	50	1.1k
Rei Mizuno Japan	17	509 1.0×	322 0.7×	454 1.1×	303 1.0×	122 0.7×	46	1.2k
Sara Tomei Qatar	20	521 1.0×	405 0.9×	534 1.3×	251 0.9×	131 0.8×	59	1.2k
Jason E. Toombs United States	21	554 1.1×	395 0.9×	542 1.3×	255 0.9×	130 0.8×	32	1.2k
Remi Adelaiye‐Ogala United States	14	563 1.1×	318 0.7×	356 0.9×	193 0.7×	312 1.9×	26	1.0k
Deblina Raychaudhuri India	11	408 0.8×	604 1.3×	461 1.1×	173 0.6×	132 0.8×	17	1.2k

Countries citing papers authored by Weina Yu

Since Specialization

Citations

This map shows the geographic impact of Weina Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weina Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weina Yu more than expected).

Fields of papers citing papers by Weina Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weina Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weina Yu. The network helps show where Weina Yu may publish in the future.

Co-authorship network of co-authors of Weina Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Weina Yu. A scholar is included among the top collaborators of Weina Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weina Yu. Weina Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yunhan, Weina Yu, Xinxin Wang, et al.. (2025). TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 ⁺ T and NK Cells. Advanced Science. 13(5). e06995–e06995. 1 indexed citations

Lei, Qingyang, Yang Li, Weina Yu, et al.. (2025). Tumor Exosomal HIF2A Induce Peritumoral M2 Macrophages Accumulation to Facilitate Intestinal Invasion in Colorectal Cancer. Theranostics. 15(15). 7709–7725.

Gao, Lei, Weina Yu, & Ce Wang. (2023). Effects of Cognitive-Behavioral Therapy on Psychological Resilience, Social Adaptation and Clinical Efficacy of Patients with Bone Tumors. Pakistan Journal of Medical Sciences. 39(4). 1045–1051. 2 indexed citations

Yu, Weina, et al.. (2022). Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis. Frontiers in Oncology. 11. 814014–814014. 9 indexed citations

Yu, Weina, Qingyang Lei, Li Yang, et al.. (2021). Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. Journal of Hematology & Oncology. 14(1). 187–187. 170 indexed citations breakdown →

Zhao, Qitai, Lan Huang, Guohui Qin, et al.. (2021). Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. Cancer Letters. 518. 35–48. 136 indexed citations

Qin, Guohui, Shasha Liu, Yang Li, Weina Yu, & Yi Zhang. (2021). Myeloid cells in COVID-19 microenvironment. Signal Transduction and Targeted Therapy. 6(1). 372–372. 14 indexed citations

Li, Yang, Aitian Li, Qitai Zhao, et al.. (2021). Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer. Frontiers in Cell and Developmental Biology. 9. 596484–596484. 9 indexed citations

Shen, Chunyi, Chaojun Liu, Ping Yü, et al.. (2021). PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer. Frontiers in Immunology. 12. 680055–680055. 20 indexed citations

10.

Lian, Jingyao, Ying Yue, Weina Yu, & Yi Zhang. (2020). Immunosenescence: a key player in cancer development. Journal of Hematology & Oncology. 13(1). 151–151. 322 indexed citations breakdown →

11.

Wang, Dan, Weina Yu, Jingyao Lian, et al.. (2020). Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients. Journal of Hematology & Oncology. 13(1). 68–68. 56 indexed citations

12.

Wu, Qian, Dan Wang, Zhen Zhang, et al.. (2020). DEFB4A is a potential prognostic biomarker for colorectal cancer. Oncology Letters. 20(4). 1–1. 11 indexed citations

13.

Wang, Dan, Yang Li, Weina Yu, et al.. (2019). Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling. Journal for ImmunoTherapy of Cancer. 7(1). 215–215. 161 indexed citations

14.

Yu, Weina, Li Yang, Ting Li, & Yi Zhang. (2019). Cadherin Signaling in Cancer: Its Functions and Role as a Therapeutic Target. Frontiers in Oncology. 9. 989–989. 148 indexed citations

15.

Wang, Dan, Weitang Yuan, Yaping Wang, et al.. (2019). Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer. Journal of Translational Medicine. 17(1). 253–253. 35 indexed citations

16.

Wang, Dan, Li Yang, Weina Yu, & Yi Zhang. (2019). Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors. Expert Opinion on Investigational Drugs. 28(10). 903–916. 6 indexed citations

17.

Yu, Weina. (2017). Alpha-1-acid glycoprotein as potential predictive biomarker of docetaxel adverse effects in breast cancer patients. Journal of Chinese Pharmaceutical Sciences. 26(12). 895–899. 1 indexed citations

18.

Li, Min, et al.. (2016). Application of Six-minuteWalk Test in Acute Stroke Patients. 22(9). 1100. 1 indexed citations

19.

Ding, Chenbo, Weina Yu, Jihong Feng, & Junmin Luo. (2015). Structure and function of Gab2 and its role in cancer (Review). Molecular Medicine Reports. 12(3). 4007–4014. 56 indexed citations

20.

Ding, Chenbo, Junmin Luo, Weina Yu, et al.. (2015). Gab2 is a novel prognostic factor for colorectal cancer patients.. PubMed. 8(3). 2779–86. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact